GAD antibody-associated neurological illness and its relationship to gluten sensitivity

Acta Neurologica Scandinavica

Volumn 123, Issue 3, 2011, Pages 175-180

  Hadjivassiliou, M ^a   Aeschlimann, D ^b   Grunewald R A ^a   Sanders, D S ^a   Sharrack, B ^a   Woodroofe, N ^c  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Anti GAD; Gluten sensitivity; Gluten free diet; Stiff person syndrome

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; GLUTEN;

ARTICLE; ATAXIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUTEN FREE DIET; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; SEROLOGY; STIFF MAN SYNDROME; UNITED KINGDOM;

ADULT; AGED; AUTOANTIBODIES; CELIAC DISEASE; COMORBIDITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTAMATE DECARBOXYLASE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 79251501668     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01356.x     Document Type: Article

References (25)

1. Kerr DIB, Ong J. GABA receptors. Pharmac Ther 1995;67:187-246.
2. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982;298:167-9.
3. Baekkeskov S, Aanstoot HJ, Christgau S et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1991;347:151-6.
4. Grubin CE, Dube S, Disteche CM et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Nat Acad Sci USA 1991;88:837-41.
5. Solimena M, Folli F, Denis-Donini S et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type 1 diabetes melitus. N Engl J Med 1988;318:1012-20.
6. Meinck HM, Thompson D. Stiff man syndrome and related conditions. Mov Disord 2002;5:853-66.
7. Leslie RDG, Atkinson MA, Notkins AL. Autoantigens IA-2 and GAD in type I (insulin dependent) diabetes. Diabetologia 1999;42:3-14.
8. Bjork E, Velloso LA, Kampe O, Karlsson A. GAD autoantibodies in IDDM, stiff man syndrome and autoimmune polyendocrine syndrome type 1 recognise different epitopes. Diabetes 1994;43:161-5.
9. Tuomilehto J, Zimmet P, Mackay IR et al. Antibodies to glutamic acid decarboxylase as predictors of insulin dependent diabetes mellitus before clinical onset of disease. Lancet 1994;343:1383-5.
10. Solimena M, Piccolo G, Martino G. Autoantibodies directed against gabaminergic nerve terminals in a patient with idiopathic late-onset cerebellar ataxia and type 1 diabetes mellitus. Clin Neuropathol 1988;7(suppl.):211.
11. Honnorat J, Saiz A, Giometto B et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies. Arch Neurol 2001;58:225-30.
12. Manto M, Laure M, Aguera M, Rogemond V, Pandolfo M, Honnorat J. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol 2007;61:544-51.
13. Sommer C, Weishaupt A, Brinkhoff J et al. Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet 2005;365:1365-7.
14. Raju R, Rakocevic G, Chen Z et al. Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome. Brain 2006;129:3270-6.
15. Kruger C, Brooking H, Rees-Smith B, Stocker W. Autoantibodies against glutamic acid decarboxylase in type 1 diabetes mellitus: a new ELISA comparable to RIA. Scientific presentation at the 7th Dresden Symposium on autoantibodies, Proceedings of the 4th Symposium on Autoantibodies, Dresden, September 2004.
16. Ballieux BEPB, Mengi Z, Bastra M, Roep B. Comparison of EIA for GAD and IA2 autoantibodies with existing radioimmunoassay. Ned Tijdschr Chem Labgeneesk 2006;31:197-8.
17. Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol 2008;64:332-43.
18. Hadjivassiliou M, Davies-Jones GAB, Sanders DS, Grünewald RAG. Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry 2003;74:1221-4.
19. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterol 1999;117:297-303.
20. Norris JM, Barriga K, Klingensmith G et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003;290:1713-20.
21. Hadjivassiliou M, Williamson CA, Woodroofe NM. The humoral response in the pathogenesis of gluten ataxia: reply from authors. Neurology 2003;60:1397-9.
22. Ishida K, Mitroma H, Song SY, Uchihara T, Inaba A, Eguchi S. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol 1999;46:263-7.
23. Boscolo S, Sarich A, Lorenzon A et al. Gluten ataxia: passive transfer in a mouse model. N.Y.Acad.Sci. 2007;1107:319-28.
24. Ellis TM, Atkinson MA. The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nature Med 1996;2:148-53.
25. Barova H, Perusicova J, Hill M, Sterzl I, Vondra K, Masek Z. Anti-GAD positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD negative patients with type 1 and type 2 diabetes mellitus. Physiol Res 2004;53:279-86.